- Latest week
- 10 Jul 2026
- Close
- 15.220000
- Fair value
- 11.750641
- Next-week expectancy
- Undecided 53.09%
SANN Chart Pack
Santhera Pharmaceuticals Holding AG
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, SANN fell 10.15%, moving from 16.94 to 15.22. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is -1.66 and has softened across the 12-week window. Market Dynamics is -0.97 on the latest week. Next-week expectancy is undecided at 53.09% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 15.22
- 12-Week Change
- -10.15%
- Trend Signal
- Active
- Next-Week Expectancy
- Undecided 53.09%
- Signal Weeks
- 12 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Above
- Relative Strength
- -1.66
- Market Dynamics
- -0.97
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 15.22
- 12-Week Change
- -10.15%
- Trend Signal
- Active
- Next-Week Expectancy
- Undecided 53.09%
- Signal Weeks
- 12 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Above
- Relative Strength
- -1.66
- Market Dynamics
- -0.97
Over the latest 12 completed weeks ending 2026-07-10, SANN fell 10.15%, moving from 16.94 to 15.22. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is -1.66 and has softened across the 12-week window. Market Dynamics is -0.97 on the latest week. Next-week expectancy is undecided at 53.09% based on similar historical setup states.
Industry Peers
Switzerland equities in Biotechnology
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| BIOV BioVersys AG | EBS | 10 Jul 2026 | 26.70 | 27.60 | 26.60 | 27.50 | 3.00% |
| MOLN Molecular Partners AG | EBS | 10 Jul 2026 | 3.18 | 3.25 | 3.16 | 3.23 | 1.57% |
| BSLN Basilea Pharmaceutica AG | EBS | 10 Jul 2026 | 54.60 | 56.30 | 52.70 | 54.70 | 0.18% |
| ADXN Addex Therapeutics Ltd | EBS | 10 Jul 2026 | 0.04 | 0.04 | 0.04 | 0.04 | 0.00% |
| BION BB Biotech AG | EBS | 10 Jul 2026 | 50.90 | 52.00 | 49.30 | 50.60 | -0.59% |
| XLS Xlife Sciences AG | EBS | 10 Jul 2026 | 18.40 | 18.90 | 17.55 | 18.15 | -1.36% |
| BANB Bachem Holding AG | EBS | 10 Jul 2026 | 78.00 | 79.15 | 71.70 | 74.85 | -4.04% |
| NWRN Newron Pharmaceuticals S.p.A. | EBS | 10 Jul 2026 | 12.32 | 12.36 | 11.72 | 11.80 | -4.22% |
| IDIA Idorsia Ltd | EBS | 10 Jul 2026 | 6.69 | 6.76 | 6.09 | 6.20 | -7.32% |
| MMTX MindMaze Therapeutics Holding SA | EBS | 10 Jul 2026 | 0.21 | 0.22 | 0.17 | 0.17 | -15.63% |